SANUWAVE Health Inc. cash flow to debt ratio of 16.87% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

SANUWAVE Health Inc.'s free cash flow has decreased 1.58% from $1.97M last year to $1.93M, signaling decreasing performance

SANUWAVE Health Inc.'s debt to equity ratio is 7.43, which means that the company's assets are unhealthy financed, signaling financial risk.

SANUWAVE Health Inc.'s debt has increased relative to shareholder equity from -2.00 last year to 7.43 today, signaling weakened financials

SANUWAVE Health Inc. has a net debt to EBITDA ratio of 0.57x, which is below the 3.00x threshold, indicating healthy leverage and financial stability

SANUWAVE Health Inc.'s interest coverage ratio is 0.19, which means that the company struggles to meet interest obligations, signaling financial risk.

SANUWAVE Health Inc.'s profit margin has increased (-133.91%) in the last year from -96.13% to 32.60%, signaling increasing performance

SANUWAVE Health Inc.'s short-term assets of $24.63M exceed its short-term liabilities of $17.85M

SANUWAVE Health Inc.'s return on assets of 39.10% is higher than the 5.00% threshold, indicating efficient asset utilization

SANUWAVE Health Inc.'s return on equity of 1.73K%, is higher than 15.00%, indicating good performance

SANUWAVE Health Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

SANUWAVE Health Inc. has insufficient public price history to evaluate earnings stability.

SANUWAVE Health Inc. has positive free cash flow, indicating the company generates cash after capital expenditures

SANUWAVE Health Inc. has a free cash flow yield of 3.93%, which is above the 2.00% threshold, indicating strong cash generation relative to market value

SANUWAVE Health Inc.'s yearly earnings has increased -137.65% since last year from $-31.37M to $11.81M, signaling increasing performance

SANUWAVE Health Inc.'s yearly revenue has increased 34.98% since last year from $32.63M to $44.05M, signaling increasing performance

ROIC 2.80% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

SANUWAVE Health Inc.'s 3-year revenue CAGR of 38.05% is positive, indicating growing revenue over the past 3 years

SANUWAVE Health Inc. has insufficient public price history to evaluate revenue consistency.

SANUWAVE Health Inc. has insufficient public price history to evaluate ROE consistency.

SANUWAVE Health Inc. has insufficient data to evaluate this check.

SANUWAVE Health Inc. has an earnings yield of 29.04%, which is above the 4.00% threshold, indicating the stock offers reasonable value relative to its earnings

SANUWAVE Health Inc. is overvalued relative to its fair value price of 3.80 based on EBITDA multiple model

SANUWAVE Health Inc. has an EV/EBITDA ratio of 3.10x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings

SANUWAVE Health Inc. has insufficient data to evaluate this check.

SANUWAVE Health Inc. had non-positive diluted EPS five years ago; the PEG ratio is not meaningful and the check fails.

SANUWAVE Health Inc. has a price-to-book ratio of 17.69x, which exceeds the 5.00x threshold, indicating the stock may be overvalued relative to its book value

SANUWAVE Health Inc. has a price-to-sales ratio of 1.12x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue